US5098977A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods and compositions for providing articles having improved biocompatability characteristics
Assignee: The University of Texas System
•
Filing: 1990-12-24
•
Granted: 1992-03-24
•
Expires: 2010-12-24
Abstract
Abstract Improved articles having reduced thrombogenicity when in contact with blood products containing albumin and methods of their preparation and use are provided. The articles comprise at the surface of blood contact a water insoluble polymeric substrate material having covalently attached thereon aliphatic extension of 12 to 22 carbon atoms. When exposed to blood, the aliphatic chain extensions provide a hydrophobic binding site for albumin. The articles when implemented with whole blood or blood products selectively enhance albumin affinity binding to the exclusion of other blood components, and subsequently minimize thrombus formation as well as other biocompatibility parameters, such as foreign body immune responses.
Inventors
- 👤 Jack Frautschi
- 👤 Kevin Tingey
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 21:03
CPC Classifications
B; B01; B01D; B01D67/00; B01D67/0081; B01D67/0093; B01D67/00931; A; A61; A61L; A61L33/00; A61L33/0076; A61L33/0088; B01D71/00; B01D71/06; B01D71/08; B01D71/10; B01D2323/00; B01D2323/38; B01D2325/00; B01D2325/48; Y; Y10; Y10S; Y10S623/00; Y10S623/924
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
129 words
A method for providing a biocompatible polymer having an affinity for albumin, the method comprising the steps of: (a) selecting a biocompatible polymer whose polymer structure includes hemicetal ring structures having adjacent secondary hydroxy groups; (b) contacting the polymer with a free radical initiator to provide a free radical carbon thereon available for covalent attachment; (c) adding a graft intermediate to free radical carbons thereon, said graft intermediate having within its structure a double bond available for addition to free radical carbons and a second site available for the addition of aliphatic extensions; and (d) derivatizing said second sites of the graft intermediate with aliphatic extensions having from 12 to 22 carbon atoms, the degree of derivatization of aliphatic extensions being effective to improve the biocompatibility of the polymer.
Claim 2
Independent Claim
129 words
A method for providing a biocompatible polymer having an affinity for albumin, the method comprising the steps of: (a) selecting a biocompatible polymer whose polymer structure includes hemicetal ring structures having adjacent secondary hydroxy groups; (b) contacting the polymer with a free radical initiator to provide a free radical carbon thereon available for covalent attachment; (c) adding a graft intermediate to free radical carbons thereon, said graft intermediate having within its structure a double bond available for addition to free radical carbons and a second site available for the addition of aliphatic extensions; and (d) derivatizing said second sites of the graft intermediate with aliphatic extensions having from 12 to 22 carbon atoms, the degree of derivatization of aliphatic extensions being effective to improve the biocompatibility of the polymer.
Claim 3
Dependent Claim
24 words
The method of claim 1 wherein said graft intermediate is selected from the group consisting essentially of vinyl pyridine; styrene; acrylamide and acrylic acid.
Claim 4
Dependent Claim
27 words
The method of claim 1 further comprising contacting the derivatized polymer with a solution which includes albumin in a manner affective to adsorb albumin to the polymer.
Claim 5
Independent Claim
132 words
A method for improving the biocompatibility of at least one surface of an article adapted for use in contact with blood or blood products containing albumin, the method comprising: (a) establishing on such a surface a biocompatible polymeric substrate whose polymeric structure includes a hemicetal ring structure having adjacent secondary hydroxyl groups; (b) contacting the polymeric substrate with a free radical initiator to provide a free radical carbon thereon available for covalent attachment; and (c) derivatizing the substrate at free radical carbons with an organic molecule having within its structure a double bond available for addition to said carbons, said molecule further including, or derivatized to include, at least one aliphatic extension having from 12 to 22 carbon atoms, the degree of derivatization being effective to improve the biocompatibility of said substrate.
Claim 6
Independent Claim
132 words
A method for improving the biocompatibility of at least one surface of an article adapted for use in contact with blood or blood products containing albumin, the method comprising: (a) establishing on such a surface a biocompatible polymeric substrate whose polymeric structure includes a hemicetal ring structure having adjacent secondary hydroxyl groups; (b) contacting the polymeric substrate with a free radical initiator to provide a free radical carbon thereon available for covalent attachment; and (c) derivatizing the substrate at free radical carbons with an organic molecule having within its structure a double bond available for addition to said carbons, said molecule further including, or derivatized to include, at least one aliphatic extension having from 12 to 22 carbon atoms, the degree of derivatization being effective to improve the biocompatibility of said substrate.
Claim 7
Dependent Claim
51 words
A composition comprising a biocompatible polymer whose structure includes hemicetal rings having adjacent secondary hydroxyl groups, wherein said hemiacetal rings have been opened and derivatized with an organic molecule which includes within its structure aliphatic extensions of from 12 to 22 carbon atoms to a degree effective to improve its biocompatibility.
Claim 8
Dependent Claim
51 words
A composition comprising a biocompatible polymer whose structure includes hemicetal rings having adjacent secondary hydroxyl groups, wherein said hemiacetal rings have been opened and derivatized with an organic molecule which includes within its structure aliphatic extensions of from 12 to 22 carbon atoms to a degree effective to improve its biocompatibility.
Claim 9
Dependent Claim
12 words
The composition of claim 5 wherein the biocompatible polymer comprises a cellulosic.
Claim 10
Dependent Claim
18 words
The composition of claim 5 wherein the biocompatible polymer comprises cellulose acetate, ethyl cellulose, cellulose nitrate, or Cuprophan®.
Claim 11
Dependent Claim
13 words
The composition of claim 5 wherein the aliphatic extensions comprise saturated aliphatic extensions.
Claim 12
Dependent Claim
26 words
The composition of claim 5 wherein the aliphatic extensions comprise extensions of CH 3 --(CH 2 ) n --, with n ranging from 11 to 21.
Claim 13
Dependent Claim
20 words
The composition of claim 5 wherein the aliphatic extension comprise extension of lauryl, myrisyl, palmityl, stearyl, arachidyl or lignoceryl moieties.
Claim 14
Dependent Claim
18 words
The composition of claim 5 wherein the aliphatic extensions comprise extensions of from 16 to 18 carbon atoms.
Claim 15
Dependent Claim
16 words
The composition of claim 5 wherein said derivatized organic molecule further comprises a quaternary nitrogen group.
Claim 16
Dependent Claim
26 words
The composition of claim 5 wherein said derivatized organic molecule further comprises vinyl pyridine groups with said aliphatic extensions covalently attached to the pyridinyl nitrogen thereof.
Claim 17
Dependent Claim
36 words
An article having at least one surface adapted for use in contact with blood or blood products containing albumin, said surface having established thereon a composition as defined by any one of claim 5 through 13.
Claim 18
Dependent Claim
35 words
The article of claim 14 which is vascular graft tubing, dialysis tubing or membrane, blood oxygenator tubing or membrane, intro-aortic balloon, ultrafiltration membrane, blood bag, catheter, suture, soft or hard tissue prosthesis, or artificial organ.
Claim 19
Dependent Claim
49 words
The method of claim 4 wherein the article which is adapted for use in contact with blood or blood products is vascular graft tubing, dialysis tubing or membrane, blood oxygenator tubing or membrane, intra-aortic balloon, ultrafiltration membrane, blood bag, catheter, suture, soft or hard tissue prosthesis, or artificial organ.
References Cited (Backward Citations)
US3051588A
Cited
US3755218A
Cited
US3853804A
Cited
US4046725A
Cited
US4116898A
Cited
US4302368A
Cited
US4501871A
Cited
US4415703A
Cited
US4530974A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-03-24 | 1995-09-23 | 1996-03-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-03-24 | 1999-09-23 | 2000-03-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-03-24 | 2003-09-23 | 2004-03-24 | $7700.00 | Window Closed / Lapsed |